Unleashing the potential of cell membrane-based nanoparticles for COVID-19 treatment and vaccination

M Pereira-Silva, G Chauhan, MD Shin… - Expert opinion on …, 2021 - Taylor & Francis
Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a particular
coronavirus strain responsible for the coronavirus disease 2019 (COVID-19), accounting for …

Shaping neonatal immunization by tuning the delivery of synergistic adjuvants via nanocarriers

S Barman, F Borriello, B Brook, C Pietrasanta… - ACS chemical …, 2022 - ACS Publications
Adjuvanted nanocarrier-based vaccines hold substantial potential for applications in novel
early-life immunization strategies. Here, via mouse and human age-specific in vitro …

Mosaic receptor binding domain nanoparticles: towards fourth-generation vaccination

VP Chavda, V Apostolopoulos - Nanomedicine, 2023 - Taylor & Francis
Throughout the time since its origin, the coronavirus has had a tendency to change
continuously, which leads to the emergence of new viral variants. Variants may have …

Challenges and future directions for next-generation biomedical polymersomes

J Shi, Q Sun, W Wang, C Li, H Yin, H Li, R Teng… - Science China …, 2024 - Springer
As a major transport system in cells, naturally occurring vesicles play an important role to
ensure that the right cargo is shipped to the right destination at the right time. Similarly …

Nanovaccines for Advancing Long-Lasting Immunity against Infectious Diseases

X Gao, X Wang, S Li, M Saif Ur Rahman, S Xu, Y Liu - ACS nano, 2023 - ACS Publications
Infectious diseases, particularly life-threatening pathogens such as small pox and influenza,
have substantial implications on public health and global economies. Vaccination is a key …

Development of T cell antigen-based human coronavirus vaccines against nAb-escaping SARS-CoV-2 variants

H Zhou, P Leng, Y Wang, K Yang, C Li, DM Ojcius… - Science Bulletin, 2024 - Elsevier
Currently approved vaccines have been successful in preventing the severity of COVID-19
and hospitalization. These vaccines primarily induce humoral immune responses; however …

The pivotal roles of the host immune response in the fine-tuning the infection and the development of the vaccines for SARS-CoV-2

W Alturaiki, A Mubarak, A Al Jurayyan… - Human Vaccines & …, 2021 - Taylor & Francis
ABSTRACT SARS-CoV2 infection induces various degrees of infections ranging from
asymptomatic to severe cases and death. Virus/host interplay contributes substantially to …

[HTML][HTML] Self-cleaning formulations of mixed metal oxide-silver micro-nano structures with spiky coronae as antimicrobial coatings for fabrics and surfaces

BM Shenoy, M Verma, S Nayak, G Hegde… - Materials …, 2024 - pubs.rsc.org
Antimicrobial coatings are essential for controlling the spread of pathogens and restricting
their interface with hosts. These may be applied to masks as additional security to wearers …

[HTML][HTML] Protein-protein conjugation enhances the immunogenicity of SARS-CoV-2 receptor-binding domain (RBD) vaccines

PV Scaria, CG Rowe, BB Chen, TH Dickey, JP Renn… - Iscience, 2022 - cell.com
Several effective SARS-CoV-2 vaccines have been developed using different technologies.
Although these vaccines target the isolates collected early in the pandemic, many have …

A cGAMP-containing hydrogel for prolonged SARS-CoV-2 RBD subunit vaccine exposure induces a broad and potent humoral response

V Böhnert, EC Gale, LJ Lahey, J Yan, AE Powell… - bioRxiv, 2021 - biorxiv.org
The SARS-CoV-2 virus spike protein, specifically its receptor binding domain (RBD), has
emerged as a promising target for generation of neutralizing antibodies. Although the RBD …